Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03425019 · ClinicalTrials.gov registry record · NA

Self Transcranial Direct Current Stimulation for Pain in Older Adults With Knee Osteoarthritis

A NA study of Chronic Pain and Knee Osteoarthritis, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
21
Enrollment target
1
Study location

NCT03425019: Completed NA study of Chronic Pain and Knee Osteoarthritis, sponsored by The University of Texas Health Science Center, Houston.

NCT03425019 is a NA study of Chronic Pain and Knee Osteoarthritis that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 21 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03425019, a NA study of Chronic Pain and Knee Osteoarthritis, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the feasibility and preliminary efficacy of two weeks of self Transcranial Direct Current Stimulation (tDCS) for pain in older patients with knee osteoarthritis (OA).

Primary Outcome

Scores on the visual analogue scale (VAS) range from 0 (no pain) to 100 (worst pain imaginable).

Interventions

  • DEVICE Soterix 1x1 tDCS mini-CT Stimulator device

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2018-03-14
Est. Completion 2018-10-05
Phase NA

What the finished NCT03425019 record still lists

NCT03425019 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Soterix 1x1 tDCS mini-CT Stimulator device is the first listed.

NCT03425019 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT03425019 about?

NCT03425019 is a clinical study titled "Self Transcranial Direct Current Stimulation for Pain in Older Adults With Knee Osteoarthritis". The purpose of this study is to determine the feasibility and preliminary efficacy of two weeks of self Transcranial Direct Current Stimulation (tDCS) for pain in older patients with knee osteoarthritis (OA).

What is the current status of trial NCT03425019?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2018-03-14. Estimated completion is 2018-10-05.

What conditions does trial NCT03425019 study?

This clinical trial studies the following conditions: Chronic Pain, Knee Osteoarthritis.

What interventions are being tested in trial NCT03425019?

The interventions under investigation include: Soterix 1x1 tDCS mini-CT Stimulator device (DEVICE).

Who is sponsoring clinical trial NCT03425019?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03425019 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03425019's enrollment target sits among peer trials

21 268th of 301 higher than 32 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02447874 · 21 participants · Phase 1

    Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • NCT03826992 · 21 participants · Phase 1

    Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

  • NCT04107077 · 21 participants · Phase 2

    Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

  • NCT04158635 · 21 participants · Phase 1

    Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03425019, the US trial registry maintained by the National Library of Medicine. NCT03425019 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.